HEALTH OF WOMAN.2015.7(103):174–177; doi 10.15574/HW.2015.103.174 
 

Diagnosis and treatment of anovulatory infertility 
 

Gladchuk I. Z., Rozhkovskaya N. M., Semenyuta O. M., Semenyuta I. O.

Odessa national medical University

Medical center "Avicenna", Melitopol 
 

Review of the literature devoted to the current problems of diagnosis and treatment of anovulatory infertility. The experience in patients with combined forms of infertility was analysed from the standpoint of evidence-based medicine. There were considered promising schemes of diagnosis and treatment of patients with various forms of anovulatory infertility. 
 

Key words: infertility, anovulation, diagnosis, treatment. 
 

REFERENCES

1. Григорян ОР, Ларина АА, Андреева ЕН, Мельниченко ГА. 2013. Гиперпролактинемия в практике гинеколога: этиология, патогенез, клиника, диагностика, лечение. Проблемы репродукции 4:14–20.

2. Дубоссарская ЗМ. 2008. Репродуктивная эндокринология (перинтальные, акушерские и гинекологические аспекты). Днепропетровск, Лира ЛТД:416.

3. Зеленина НВ, Молчанов ОЛ, Бескровный СВ. 2012. Дифференцированное медикаментозное лечение бесплодия при синдроме поликистозных яичников. Вестник Российской военно-медицинской академии 4:111–115.

4. Калугина ЛВ, Ефименко ОА. 2012. Опыт лечения СПКЯ. Репродуктивная эндокринология 2(4):74–78.

5. Кирмасасова АВ, Назаренко ТА, Дуринян ЭР. 2010. Клинико-лабороторные фенотипы у пациенток молодого возраста с синдромом поликистозных яичников. Российский вестник акушера-гинеколога 10;2:52–55.

6. Короткова СА, Богданова ЕА, Казначеева ТВ и др. 2012. Редкие заболевания в гинекологии: андроген-продуцирующие опухоли яичников. Медицинский вестник МВД 2(57):38–42.

7. Можейко ЛФ, Лобачевская ОС, Романчук ЖВ и др. 2014. Современные методы лечения бесплодия при СПКЯ. Охрана материнства и детства 1(23):104–106.

8. Трушкевич АА. 2008. Клинические аспекты современного алгоритма обследования женщин с гиперпролактинемическими состояниями. Репродуктивное здоровье женщины: Всеукраинский научно-практический журнал 4:191–192.

9. Sielert L, Liu C, Nagarathinam R, Craig LB. 2013. Androgen-producing steroid cell ovarian tumor in a young woman and subsequent spontaneous pregnancy. J Assist Reprod Genet. 30(9):1157–1160. http://dx.doi.org/10.1007/s10815-013-0051-9; PMid:23868533 PMCid:PMC3800527

10. Lynch KE, Mumford SL, Schliep KC et al. 2014. Assessment of anovulation in eumenorrheic women: comparison of ovulation detection algorithms. Fertil Steril. 102(2):511–518. http://dx.doi.org/10.1016/j.fertnstert.2014.04.035

11. Farquhar C, Rishworth JR, Brown J et al. 2014. Assisted reproductive technology: an overview of Cochrane reviews. Cochrane Database Syst Rev. 12:CD010537. http://dx.doi.org/10.1002/14651858.cd010537.pub3

12. Balen AH. Infertility in Practice (Reproductive Medicine and Assisted Reproductive Techniques Series). CRC Press:516.

13. Douglas T, Carrell (Editor), Peter N Schlegel (Editor), Catherine Racowsky (Editor), Luca Gianaroli (Editor). 2015. Biennial Review of Infertility. Vol. 4 NY Springer: 510.

14. Ecklund LC, Usadi RS. 2015. Endocrine and reproductive effects of polycystic ovarian syndrome. Obstet Gynecol Clin North Am. 42(1):55–65. http://dx.doi.org/10.1016/j.ogc.2014.09.003; PMid:25681840

15. Hayes F, Dwyer A, Pitteloud N. Hypogonadotropic Hypogonadism (Hh) and Gonadotropin Therapy. In: De Groot LJ, Beck-Peccoz P, Chrousos G et al. Endotext Internet. South Dartmouth (MA): MDText.com

16. Hohl A, Ronsoni MF, Oliveira Md. 2014. Hirsutism: diagnosis and treatment. Arq Bras Endocrinol Metabol. 58(2):97–107. http://dx.doi.org/10.1590/0004-2730000002923; PMid:24830586

17. Homburg R, Springer NY. 2014. Ovulation Induction and Controlled Ovarian Stimulation: A Practical Guide, 2nd ed:268. http://dx.doi.org/10.1007/978-3-319-05612-8

18. Alpaсйs M, Luque-Ramнrez M, Martнnez-Garcнa MБ et al. 2015. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome. Fertil Steril. 103(3):795–801. http://dx.doi.org/10.1016/j.fertnstert.2014.12.105; PMid:25585504

19. Ozkaya E, Cakir E, Cinar M et al. 2012. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS? Gynecol Endocrinol. 28(6):468–471. http://dx.doi.org/10.3109/09513590.2011.633658; PMid:22103710

20. Chene G, Penault-Llorca F, Tardieu A et al. 2012. Is There a Relationship between Ovarian Epithelial Dysplasia and Infertility? Obstet Gynecol Int. 2012:429085. http://dx.doi.org/10.1155/2012/429085; PMid:22496700 PMCid:PMC3306969

21. Kovanci E, Schutt AK. 2015. Premature ovarian failure: clinical presentation and treatment. Obstet Gynecol Clin North Am. 42(1):153–161. http://dx.doi.org/10.1016/j.ogc.2014.10.004; PMid:25681846

22. Lindsay TJ, Vitrikas KR. 2015. Evaluation and treatment of infertility. Am Fam Physician 91(5):308–314. PMid:25822387

23. Prince JL, Links JL. 2014. Medical Imaging Signals and Systems. Prentice Hall:544.

24. Barry JA, Moran E, Parekh HS et al. 2014. Prolactin and aggression in women with fertility problems. J Obstet Gynaecol. 34(7):605–610. http://dx.doi.org/10.3109/01443615.2014.901302; PMid:25226401 PMCid:PMC4221019

25. Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. 2014. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? Iran J Reprod Med. 12(7):481–486. PMid:25114670 PMCid:PMC4126252

26. Ragab A, Barakat R, Ragheb M et al. 2012. Subfertility treatment in women with systemic lupus erythematosus. J Obstet Gynaecol. 32(6):569–571. http://dx.doi.org/10.3109/01443615.2012.693986; PMid:22779964

27. Witek B, El Wakil A, Nord C et al. 2015. Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic Hypogonadism. PLoS One. 10(5):e0123542 http://dx.doi.org/10.1371/journal.pone.0123542; PMid:25955180 PMCid:PMC4425494

28. Corbett S, Shmorgun D, Claman P et al. 2014. The prevention of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 36(11):1024–1036. http://dx.doi.org/10.1016/S1701-2163(15)30417-5

29. Glintborg D, Altinok ML, Petersen KR, Ravn P. 2015. Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours. BMJ Case Rep.:2015. http://dx.doi.org/10.1136/bcr-2014-204797

30. Beksac S, Selзuk I, Boyraz G et al. 2013. Two patients with marginal symptoms showing hyperthecosis at the edge of malignancy: Presentation of two cases. J Turk Ger Gynecol Assoc. 14(3):182–185. http://dx.doi.org/10.5152/jtgga.2013.88964